Introduction: Cervical cancer is the fourth most common cancer in women worldwidev . Most patients in developing countries including Bangladesh present at advanced stage. Histopathological types of cervical cancer influence the treatment outcome when treated by radiation therapy.
Introduction:
Cervical cancer is a major global public health problem and the fourth world wide leading cause of cancer death in women¹.
In Bangladesh, cervical cancer is the second common cancer in women after breast². To reduce mortality from cervical cancer and improve survival, it is necessary to identify the prognostic factors.
Among the gynecological malignancies, the most common cases attending GOPD of NICRH is cervical cancer³. Most of them are in advanced stage disease & treated with radiotherapy. Early stage of cervical cancer is defined as FIGO stages I to IIA and advanced stage in defined as stage IIB to IVBt. Several studies have reported that histopathological type is an important prognostic factor in advanced stage cervical canceru --'v. Other factors such as clinical stage, cell differentiation, treatment modality are also prognostic factors for cervical cancerv 'w .
The present study was carried out to find out the prognostic impact of histopathological type of cervical cancer on disease free survival (DFS), local (cervical)/ loco-regional (pelvic) recurrence and distal recurrence after completion of treatment with RT.
Methods:
It was a prospective cohort study conducted in gynecological oncology outpatient department (GOPD) of National Institute of Cancer Research &Hospital (NICRH) during the period of September 2016 to September 2017 (one year). Sampling technique was purposive. Advanced stage (IIB-IVB) cervical cancer who completed radiation therapy and histopathological type either squamous cell carcinoma or adenocarcinoma of cervical cancer were included in this study and early stage (IB-IIA) cervical cancer, patients with incomplete treatment and any malignancy other than cervical cancer were excluded from this study. Formal permission was taken from the ethical committee of the NICRH, Dhaka. Cervical cancer cases were diagnosed by history, clinical examination and histological confirmation of biopsy specimen from cervix. Inform consent was taken from each patient before enrollment. Data were collected in a pre-designed data collection sheet. Clinical and pathological data were collected from medical records, pathology reports, and cancer registry reports. Followup schedule was every 03 months. Every patient was evaluated by history taking, complete physical examination. If there was any suspicious of recurrence on clinical evaluation, than USG/CT scan of whole abdomen & pelvis and chest X -Ray was advised. All recurrence was confirmed by tissue diagnosis. Data were analyzed using SPSS software. A p value <0.05 was regarded as statistically significant.
Result:
One hundred and fifty biopsy proven advanced stage (IIB -IVB) cases of cervical carcinoma were included in this study. Mean age was 48 yrs (range 35-66 yrs). Mean follow-up time was 1.82(yrs) and range was (0.08-2 yrs). Table 1 : showing clinicopathological characteristic of the study population. Figure 1 : shows average DFS was 1.53 years in Squamous cell carcinoma and 1.51 years in Adenocarcinoma but findings was not statistically significant. Figure2: shows adenocarcinoma histopathological type was associated with shorter DFS. The differences was not statistically significant (<0.05). Table II: showing local (cervix) recurrence (62.5%) in ADC than SSC (30.5%) and found statistically significant (p=0.001). local pelvic recurrence was higher in ADC (12.5%) than SSC (8.5%). Distal recurrence was also higher in ADC than SSC which was 6.2% VS 5.1% respectively .Both of the differences were not statistically significant (> 0.05). Table III: shows univariate analysis, shorter disease-free survival in both SSC and ADC in relation to advanced stage of cervical cancer. Table IV: shows local recurrence was higher in stage IIIB (50%) and local regional recurrence was also higher in stage IIIB (57.1%). Both of the differences were statistically significant (<0.05%). Multivariate analysis revealed that histopathological type and stages of cervical cancer were independent significant predictors for DFS of the patients. Hazard ration of histopathological type and stages were being 1.76 (q= .018) and 2.17(q =.006). (Table VI ) treated by radiation therapy.This study showed that, Disease free survival was longer in squamous cell carcinoma cases (1.53 years) than adenocarcinoma (1.51 years).
In case of squamous cell carcinoma, 83.9% of patients were disease free for more than 01 years and in adenocarcinoma, 75% of patients were disease free for more than one year. Similar findings were found in several other studiesv 'w . In one studyx , patients with ADC had a poorer survival than SSC, particularly among the patients with advanced stage and indicate a strong impact of Adenocarcinoma compared with squamous cell carcinoma. Another studyy reported that the DFS and OS (overall survival) of patients with adenocarcinoma were significantly shorter than that of patients with SSC. One Japanese study¹p reported that non-squamous histopathological type was the first independent risk factor when all relevant factors were taken into account. One Chinese study¹¹ reported that adenocarcinoma was an independent factor OS (HR= 7.83; 95% CI=2. In this study, among total number of SSC (118) cases, local recurrences was 36 (30.5%) and total number of ADC (32) cases, local recurrences was 20 62.5%). Local (cervical) recurrence was significantly higher in ADC than SSC (p=0.001). Local pelvic recurrence occurred in 10 patients of SSC (8.5%) and 4 patients in ADC (12.5%). Local regional recurrence is higher in ADC than SCC. Distal recurrence was also high in ADC type (6.2%) than SSC (5.1%). Several other studies have similar finding ¹¹´¹³´¹t ´¹v . In one study¹v reported that in case of SCC, 25.0% case had loco regional recurrence and 36.1% had distant failure. In case of ADC, 32.7% developed loco-regional recurrence and 49.1% had distant recurrence. Eifel al¹w analyzed 229 patients with cervical carcinoma and reported that the incidence of the pelvic recurrence was 17% for ADC and 13% for SSC. Also reported that distant metastasis were more frequent in patient with adenocarcinoma than SSC (37% VS 21% p=0.01). In this study finding ADC has higher local recurrence, pelvic recurrence, metastasis than SSC. One Taiwan study¹¹ reported that local failure free survival for adenocarcinoma and Squamous cell 
Discussion:
The factors, which affect the prognosis of patients with cervical cancer, are very complex and interactive and they jointly affect the prognosis of patients. This study revealed that Histopathological type was an important prognostic factor in advanced stage cervical cancer In this study revealed that local recurrence was more common in stage IIIB (50.0%) than stage IIB (42.9%). This finding was similar to several other studies¹³´¹t ´¹v reported that local recurrence was more common according to advance stage cervical carcinoma.
In current study local regional recurrence is higher in stage IIIB (57.1%) than stage IIB (42.9%). Loco-regional recurrence is higher in advanced stage cervical carcinoma in following study ¹³´¹t ´¹v .
In present study, 37% of cases with stage IIB or III had local recurrence after RT and 14.6% of cases with stage IIB or III had distant metastasis after RT. Nakano et at¹x reported that the rate of distant failure after RT was 14% for stage II disease and 25% for stage III disease.
Conclusion:
Histopathological type of adenocarcinoma is a significant and independent prognostic factor for disease free survival and local recurrence in advanced stage cervical carcinoma patient treated with radiotherapy. Advanced stage cervical carcinoma is also significant and independent prognostic factor in DFS, local recurrence and metastasis. This finding may be useful for further tailored treatment-strategies and follow-up planning among patients in each histopathological type.
